Publication:  Regressing anaplastic CD30-positive large-cell lymphoma of the skin
| dc.contributor.author | Skiljevic, Dusan (23487265400) | |
| dc.contributor.author | Nikolic, Milos M. (56910382000) | |
| dc.contributor.author | Milinkovic, Mirjana (57218644212) | |
| dc.contributor.author | Bonaci-Nikolic, Branka (10839652200) | |
| dc.date.accessioned | 2025-06-13T00:07:31Z | |
| dc.date.available | 2025-06-13T00:07:31Z | |
| dc.date.issued | 2006 | |
| dc.description.abstract | Originally believed to be of histiocytic origin, regressing primary cutaneous anaplastic large-cell lymphoma is a CD30 (Ki 1) positive T-cell lymphoma with histologic high grade malignancy, but with an often favorable clinical course with regression of individual lesions. We present a case of a 69-year-old white woman with an 8-month history of noduloulcerative lesions on her right lower leg, otherwise in good general health. The clinical, histologic, and immunohistochemical findings pointed to CD30 positive primary cutaneous anaplastic large-cell lymphoma. There were no signs of generalization, lymph node or internal organ involvement. After 2 years of activity, the disease regressed. During the 10-year follow-up period, no signs of disease reactivation were noted. Accurate recognition of this lymphoma is important to avoid unnecessary aggressive treatments. | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749619549&partnerID=40&md5=009014ae4a37695fce0f11394feae4dc | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/10878 | |
| dc.subject | CD30 positive | |
| dc.subject | Large cell lymphoma | |
| dc.subject | Regressing | |
| dc.subject | Skin | |
| dc.title | Regressing anaplastic CD30-positive large-cell lymphoma of the skin | |
| dspace.entity.type | Publication | 
